Endocrinology, Vol 137, 712-721, Copyright © 1996 by Endocrine Society

ARTICLES

Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild- type/mutant receptor heterodimer

XG Zhu, CL Yu, P McPhie, R Wong and SY Cheng
Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

The clinical manifestations of patients with resistance to thyroid hormone result from inhibition of the functions of wild-type thyroid hormone receptors (wTRs) by the dominant negative effect of mutant TR beta 1 receptors (mTR beta 1). One of the proposed mechanisms by which mTR beta 1 exerts its dominant negative action is via formation of the putative inactive wTR beta 1/mTR beta 1 heterodimer. However, the nature of the wTR beta 1/mTR beta 1 heterodimer is poorly understood. The present study characterizes the wTR beta 1/mTR beta 1 heterodimer by electrophoretic mobility shift assay. The mutant TR beta 1 used was PV, which contains a frame shift mutation in the C-terminal part of TR beta 1 and has less than 1% of the T3 binding affinity of the wTR beta 1. Because of the difficulty in resolving wTR beta 1 and mutant PV dimers, we used a truncated wTR beta 1 in which the A/B domain was deleted (delta TR beta 1) to demonstrate the formation of the heterodimer on thyroid hormone response elements (TREs) in which the half-site binding motifs are oriented in an inverted repeat (F2), a direct repeat separated by four nucleotides (DR4), or an inverted repeat (Pal). Deletion of the A/B domain had no effect on the binding of T3 and TREs to wTR beta 1. In the presence of equal amounts of delta TR beta 1 and PV, three types of molecular complexes. delta TR beta 1 homodimer, delta TR beta 1/PV heterodimer, and PV homodimer bound to each TRE in a ratio of approximately 1:2:1. The identities of these complexes were confirmed by their ability to be supershifted by anti-TR beta 1 and/or anti-PV antibodies. delta TR beta 1/PV heterodimer formation varied with different TREs. The ratio of apparent affinity constant (Ka) in the binding of delta TR beta 1/PV to TREs was F2:DR4:Pal = approximately 6:2:1. The effect of T3 on delta TR beta 1/PV heterodimer formation was TRE dependent. No T3-induced dissociation was observed for the delta TR beta 1/PV heterodimer when bound to F2 and Pal. In contrast, the delta TR beta 1/PV heterodimer bound to DR4 was dissociated by T3 with an ED50 of 3.9 +/- 0.9 nM. The T3-induced dissociation of delta TR beta 1 homodimer bound to F2, DR4, and Pal had ED50 values of 4.1 +/- 1.2, 1.3 +/- 0.3, and more than 100 nM, respectively. By transfection assays, the dominant negative action of PV was found to be TRE dependent with the rank order of F2 >> Pal > ME (a DR4-like TRE in the rat malic enzyme gene). Taken together, these results indicate a strong correlation between wTR beta 1/mTR beta 1 heterodimer formation and the dominant negative potency of PV. These results suggest that the wTR beta 1/mTR beta 1 heterodimer could play an important role in the dominant negative action of mTR beta 1.

This article has been cited by other articles:

				P. J. O'Shea, C. B. Harvey, H. Suzuki, M. Kaneshige, K. Kaneshige, S.-Y. Cheng, and G. R. Williams A Thyrotoxic Skeletal Phenotype of Advanced Bone Formation in Mice with Resistance to Thyroid Hormone Mol. Endocrinol., July 1, 2003; 17(7): 1410 - 1424. [Abstract] [Full Text] [PDF]

				H. Suzuki, X.-Y. Zhang, D. Forrest, M. C. Willingham, and S.-Y. Cheng Marked Potentiation of the Dominant Negative Action of a Mutant Thyroid Hormone Receptor {beta} in Mice by the Ablation of One Wild-Type {beta} Allele Mol. Endocrinol., May 1, 2003; 17(5): 895 - 907. [Abstract] [Full Text] [PDF]

				X.-Y. Zhang, M. Kaneshige, Y. Kamiya, K. Kaneshige, P. McPhie, and S.-Y. Cheng Differential Expression of Thyroid Hormone Receptor Isoforms Dictates the Dominant Negative Activity of Mutant {beta} Receptor Mol. Endocrinol., September 1, 2002; 16(9): 2077 - 2092. [Abstract] [Full Text] [PDF]

				M. Kaneshige, K. Kaneshige, X.-g. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, et al. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone PNAS, November 2, 2000; (2000) 230285997. [Abstract] [Full Text]

				K.-h. Lin, X.-G. Zhu, H.-C. Hsu, S.-L. Chen, H.-y. Shieh, S.-T. Chen, P. McPhie, and S.-y. Cheng Dominant Negative Activity of Mutant Thyroid Hormone {alpha}1 Receptors from Patients with Hepatocellular Carcinoma Endocrinology, December 1, 1997; 138(12): 5308 - 5315. [Abstract] [Full Text] [PDF]

				X.-G. Zhu, P. McPhie, K.-H. Lin, and S.-Y. Cheng The Differential Hormone-dependent Transcriptional Activation of Thyroid Hormone Receptor Isoforms Is Mediated by Interplay of Their Domains J. Biol. Chem., April 4, 1997; 272(14): 9048 - 9054. [Abstract] [Full Text] [PDF]

				M. Behr, D. B. Ramsden, and U. Loos Deoxyribonucleic Acid Binding and Transcriptional Silencing by a Truncated c-erbA{beta}1 Thyroid Hormone Receptor Identified in a Severely Retarded Patient with Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1081 - 1087. [Abstract] [Full Text] [PDF]

				X.-G. Zhu, P. McPhie, and S.-y. Cheng Differential Sensitivity of Thyroid Hormone Receptor Isoform Homodimers and Mutant Heterodimers to Hormone-Induced Dissociation from Deoxyribonucleic Acid: Its Role in Dominant Negative Action Endocrinology, April 1, 1997; 138(4): 1456 - 1463. [Abstract] [Full Text] [PDF]

				A. Dace, L. Zhao, K. S. Park, T. Furuno, N. Takamura, M. Nakanishi, B. L. West, J. A. Hanover, and S.-y. Cheng Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors PNAS, August 1, 2000; 97(16): 8985 - 8990. [Abstract] [Full Text] [PDF]

				M. Kaneshige, K. Kaneshige, X.-g. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, et al. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone PNAS, November 21, 2000; 97(24): 13209 - 13214. [Abstract] [Full Text] [PDF]